Roundhill Investments - GLP-1 & Weight Loss ETF
ETFYour view on OZEM
Roundhill Investments - GLP-1 & Weight Loss ETF
ETFRoundhill InvestmentsSentiment
AUM (USD)
$64.64M
Expense Ratio
0.59%
Holdings
29
Sentiment
Overview for Roundhill Investments - GLP-1 & Weight Loss ETF
- Fund Type
- ETF
- Fund Issuer
- Roundhill Investments
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 21, 2024
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Roundhill Investments
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 21, 2024
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Roundhill Investments
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 21, 2024
- Domicile
- US
About this fund
Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
OZEM Stock Price
Key Facts
EquityExpense Ratio
0.59%
AUM
$64.64M
Fund Details
Expense Ratio
0.59%
Assets Under Management
$64.64M
NAV
$33.49 USD
Holdings
29
Average Volume
17.5K
Inception Date
May 21, 2024
Asset Class
Equity
Fund Issuer
Roundhill Investments
Domicile
US
ISIN
US77926X8829
CUSIP
77926X882
NAV Currency
USD
Expense Ratio
0.59%
Assets Under Management
$64.64M
NAV
$33.49 USD
Holdings
29
Average Volume
17.5K
Inception Date
May 21, 2024
Asset Class
Equity
Fund Issuer
Roundhill Investments
Domicile
US
ISIN
US77926X8829
CUSIP
77926X882
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.